UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program

Pediatric blood & cancer, 2016-10, Vol.63 (10), p.1744-1752

2016

Volltextzugriff (PDF)

Levels of stress and intervention preferences of caregivers of brain tumor patients

Cancer nursing, 2007-11, Vol.30 (6), p.E33-E39

Keir, Stephen T

2007

Volltextzugriff (PDF)

IDENTIFICATION AND PRELIMINARY TREATMENT DATA OF XENOGRAFTS REPRESENTING TCGA-DEFINED SUBTYPES

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii35-iii35

2014

Volltextzugriff (PDF)

PATIENT-DERIVED XENOGRAFTS MIRROR THE PROTEOMIC PROFILE OF HUMAN GLIOBLASTOMA: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii38-iii38

2014

Volltextzugriff (PDF)

Distress persists in long-term brain tumor survivors with glioblastoma multiforme

Journal of cancer survivorship, 2008-12, Vol.2 (4), p.269-274

2008

Volltextzugriff (PDF)

DNAR-08. THE ROLE OF SMARCAL1 AS A SYNTHETIC LETHAL VULNERABILITY IN ATRX-DEFICIENT GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii91-vii92

2022

Volltextzugriff (PDF)

LGG-01. EVALUATION OF COBIMETINIB, A MEK INHIBITOR, IN LOW-GRADE PEDIATRIC BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i104-i105

2018

Volltextzugriff (PDF)

TMOD-27. EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii233-ii233

2020

Volltextzugriff (PDF)

EXTH-57. EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi176-vi176

2021

Volltextzugriff (PDF)

TMOD-33. ESTABLISHMENT AND PRELIMINARY EVALUATION OF BEVACIZUMAB-RESISTANT GLIOMA XENOGRAFT MODELS

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi275-vi275

2018

Volltextzugriff (PDF)

[177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma

Current radiopharmaceuticals, 2010-01, Vol.3 (1), p.29-36

2010

Volltextzugriff (PDF)

IMMU-34. ATRX MUTATIONS PREDICT RESPONSE TO INNATE BASED THERAPY IN GLIOMA

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi126-vi126

2019

Volltextzugriff (PDF)

IMMU-18. INTERPLAY BETWEEN IDH1 AND ATRX MUTATIONS GOVERN INNATE IMMUNE RESPONSES IN GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii108-ii108

2020

Volltextzugriff (PDF)

ET-28COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v85-v85

2014

Volltextzugriff (PDF)

BSCI-20 STING EPIGENETIC SILENCING IN GLIOMAS CAN BE RESCUED BY METHYLTRANSFERASE INHIBITION: IMPLICATIONS FOR NOVEL THERAPEUTIC APPROACHES

Neuro-oncology advances, 2022-08, Vol.4 (Supplement_1), p.i5-i5

2022

Volltextzugriff (PDF)

ET-28 COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v85-v85

2014

Volltextzugriff (PDF)

Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program: LOCK ET AL

Pediatric blood & cancer, 2017-04, Vol.64 (4), p.e26263

2017

Volltextzugriff (PDF)

Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program: Kurmasheva et al

Pediatric blood & cancer, 2017-04, Vol.64 (4), p.e26304

2017

Volltextzugriff (PDF)

QLIF-20. A CROSS-SECTIONAL STUDY OF DISTRESS THROUGHOUT THE DISEASE TRAJECTORY IN PRIMARY BRAIN TUMOR PATIENTS

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi160-vi160

2016

Volltextzugriff (PDF)

Lipophilic Mn Porphyrins in the Treatment of Brain Tumors

Free radical biology & medicine, 2011-11, Vol.51, p.S119-S120

2011

Volltextzugriff (PDF)

Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program: Testing of NSC 750854, a Novel Purine Analog

Pediatric blood & cancer, 2016-03, Vol.63 (3), p.443-450

2016

Volltextzugriff (PDF)

A Therapeutic Antibody for Cancer, Derived from Single Human B Cells

Cell reports (Cambridge), 2016-05, Vol.15 (7)

2016

Volltextzugriff (PDF)

Abstract C206: Pediatric Preclinical Testing Program (PPTP) evaluation of BMN 673, an inhibitor of Poly-ADP Ribose Polymerase (PARP), alone and with Temozolomide (TMZ)

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.C206-C206

2013

Volltextzugriff (PDF)

Mechanistic Considerations of the Therapeutic Effects of Mn Porphyrins, Commonly Regarded as SOD Mimics, in Anticancer Therapy: Lessons from Brain and Lymphoma Studies

Free radical biology & medicine, 2013-11, Vol.65, p.S120-S121

2013

Volltextzugriff (PDF)

PSS267 - Mechanistic Considerations of the Therapeutic Effects of Mn Porphyrins, Commonly Regarded as SOD Mimics, in Anticancer Therapy: Lessons from Brain and Lymphoma Studies

Free radical biology & medicine, 2013-11, Vol.65, p.S120-S121

2013

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Zeitschrift / SerieCancer Chemotherapy And Pharmacology

ThemaMice, Nude

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(60)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(71)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program

Levels of stress and intervention preferences of caregivers of brain tumor patients

IDENTIFICATION AND PRELIMINARY TREATMENT DATA OF XENOGRAFTS REPRESENTING TCGA-DEFINED SUBTYPES

PATIENT-DERIVED XENOGRAFTS MIRROR THE PROTEOMIC PROFILE OF HUMAN GLIOBLASTOMA: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT

Distress persists in long-term brain tumor survivors with glioblastoma multiforme

DNAR-08. THE ROLE OF SMARCAL1 AS A SYNTHETIC LETHAL VULNERABILITY IN ATRX-DEFICIENT GLIOMAS

LGG-01. EVALUATION OF COBIMETINIB, A MEK INHIBITOR, IN LOW-GRADE PEDIATRIC BRAIN TUMORS

TMOD-27. EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA

EXTH-57. EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA

TMOD-33. ESTABLISHMENT AND PRELIMINARY EVALUATION OF BEVACIZUMAB-RESISTANT GLIOMA XENOGRAFT MODELS

[177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma

IMMU-34. ATRX MUTATIONS PREDICT RESPONSE TO INNATE BASED THERAPY IN GLIOMA

IMMU-18. INTERPLAY BETWEEN IDH1 AND ATRX MUTATIONS GOVERN INNATE IMMUNE RESPONSES IN GLIOMAS

ET-28COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB

BSCI-20 STING EPIGENETIC SILENCING IN GLIOMAS CAN BE RESCUED BY METHYLTRANSFERASE INHIBITION: IMPLICATIONS FOR NOVEL THERAPEUTIC APPROACHES

ET-28 COMBINATION THERAPY WITH MET TYROSINE KINASE INHIBITOR EMD1214063 AND BEVACIZUMAB

Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program: LOCK ET AL

Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program: Kurmasheva et al

QLIF-20. A CROSS-SECTIONAL STUDY OF DISTRESS THROUGHOUT THE DISEASE TRAJECTORY IN PRIMARY BRAIN TUMOR PATIENTS

Lipophilic Mn Porphyrins in the Treatment of Brain Tumors

Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program: Testing of NSC 750854, a Novel Purine Analog

A Therapeutic Antibody for Cancer, Derived from Single Human B Cells

Abstract C206: Pediatric Preclinical Testing Program (PPTP) evaluation of BMN 673, an inhibitor of Poly-ADP Ribose Polymerase (PARP), alone and with Temozolomide (TMZ)

Mechanistic Considerations of the Therapeutic Effects of Mn Porphyrins, Commonly Regarded as SOD Mimics, in Anticancer Therapy: Lessons from Brain and Lymphoma Studies

PSS267 - Mechanistic Considerations of the Therapeutic Effects of Mn Porphyrins, Commonly Regarded as SOD Mimics, in Anticancer Therapy: Lessons from Brain and Lymphoma Studies

Aktive Filter

Suchergebnisse filtern